{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:36:26Z","timestamp":1789724186206,"version":"4.0.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Projects of Science and Technology of Henan Province","award":["242102310426, 252102310517"],"award-info":[{"award-number":["242102310426, 252102310517"]}]},{"name":"Program for Science and Technology Innovation Talents in Universities of Henan Province","award":["23HASTIT042"],"award-info":[{"award-number":["23HASTIT042"]}]},{"name":"Medical Science and Technology Project of Henan Province","award":["SBGJ202402079"],"award-info":[{"award-number":["SBGJ202402079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10495-025-02216-8","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:05:00Z","timestamp":1768039500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of LDHA promotes GSDME-dependent pyroptosis by activating RIG-I-like receptor signaling"],"prefix":"10.1007","volume":"31","author":[{"given":"Cuiqing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"2216_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2216_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16:589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2216_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jnci\/djaa119","volume":"113","author":"H Lim","year":"2021","unstructured":"Lim H, Ramjeesingh R, Liu D et al (2021) Optimizing survival and the changing landscape of targeted therapy for intermediate and advanced hepatocellular carcinoma: a systematic review. J Natl Cancer Inst 113:123\u2013136","journal-title":"J Natl Cancer Inst"},{"key":"2216_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s40425-019-0824-5","volume":"7","author":"M Hilmi","year":"2019","unstructured":"Hilmi M, Neuzillet C, Calderaro J et al (2019) Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions. J Immunother Cancer 7:333","journal-title":"J Immunother Cancer"},{"key":"2216_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","volume":"72","author":"AL Cheng","year":"2020","unstructured":"Cheng AL, Hsu C, Chan SL, Choo SP, Kudo M (2020) Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol 72:307\u2013319","journal-title":"J Hepatol"},{"key":"2216_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"DY Li","year":"2021","unstructured":"Li DY, Wu MH (2021) Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 6:291","journal-title":"Signal Transduct Target Ther"},{"key":"2216_CR7","doi-asserted-by":"publisher","first-page":"e01085-19","DOI":"10.1128\/JVI.01085-19","volume":"93","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Karijolich J (2019) Know thyself: RIG-I-like receptor sensing of DNA virus infection. J Virol 93:e01085-19","journal-title":"J Virol"},{"key":"2216_CR8","doi-asserted-by":"publisher","first-page":"e1009111","DOI":"10.1371\/journal.ppat.1009111","volume":"17","author":"KA Khan","year":"2021","unstructured":"Khan KA, Marineau A, Doyon P et al (2021) TRK-fused gene (TFG), a protein involved in protein secretion pathways, is an essential component of the antiviral innate immune response. PLoS Pathog 17:e1009111","journal-title":"PLoS Pathog"},{"key":"2216_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-023-01405-9","volume":"16","author":"YF Jiang","year":"2023","unstructured":"Jiang YF, Zhang HY, Wang J et al (2023) Exploiting RIG-I-like receptor pathway for cancer immunotherapy. J Hematol Oncol 16:8","journal-title":"J Hematol Oncol"},{"key":"2216_CR10","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1158\/0008-5472.CAN-24-3425","volume":"85","author":"N Soliman","year":"2025","unstructured":"Soliman N, Nedelko T, Mandracci G et al (2025) Targeting intracellular innate RNA-sensing systems overcomes resistance to CAR T-cell therapy in solid tumors. Cancer Res 85:2679\u20132693","journal-title":"Cancer Res"},{"key":"2216_CR11","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-18-0730","volume":"78","author":"DL Elion","year":"2018","unstructured":"Elion DL, Jacobson ME, Hicks DJ et al (2018) Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers. Cancer Res 78:6183\u20136195","journal-title":"Cancer Res"},{"key":"2216_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois D, Loo Yau H, Singhania R et al (2015) DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162:961\u2013973","journal-title":"Cell"},{"key":"2216_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.apsb.2020.06.015","volume":"10","author":"XW Zhang","year":"2020","unstructured":"Zhang XW, Zhang P, An L et al (2020) Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Acta Pharm Sin B 10:1397\u20131413","journal-title":"Acta Pharm Sin B"},{"key":"2216_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"YP Wang","year":"2017","unstructured":"Wang YP, Gao WQ, Shi XY et al (2017) Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547:99\u2013103","journal-title":"Nature"},{"key":"2216_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41420-022-00894-w","volume":"8","author":"N Li","year":"2022","unstructured":"Li N, Chen J, Geng C et al (2022) Myoglobin promotes macrophage polarization to M1 type and pyroptosis via the RIG-I\/Caspase1\/GSDMD signaling pathway in CS-AKI. Cell Death Discov 8:90","journal-title":"Cell Death Discov"},{"key":"2216_CR16","doi-asserted-by":"publisher","first-page":"2504244","DOI":"10.1080\/2162402X.2025.2504244","volume":"14","author":"S Enssle","year":"2025","unstructured":"Enssle S, Sax A, May P et al (2025) Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy. Oncoimmunology 14:2504244","journal-title":"Oncoimmunology"},{"key":"2216_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/gutjnl-2024-332281","volume":"74","author":"YL Tu","year":"2025","unstructured":"Tu YL, Wu HR, Zhong CP et al (2025) Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma. Gut 74:613\u2013627","journal-title":"Gut"},{"key":"2216_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41416-024-02908-z","volume":"132","author":"M Deng","year":"2025","unstructured":"Deng M, Zhao RC, Zou H et al (2025) Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma. Br J Cancer 132:371\u2013383","journal-title":"Br J Cancer"},{"key":"2216_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ebiom.2019.03.019","volume":"42","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang LM, Li YR et al (2019) Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca\/calcineurin\/Erk pathway. EBioMedicine 42:326\u2013339","journal-title":"EBioMedicine"},{"key":"2216_CR20","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.1038\/s41467-023-44176-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Fang H, Wang G et al (2023) Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells. Nat Commun 14:8491","journal-title":"Nat Commun"},{"key":"2216_CR21","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.18632\/oncotarget.2750","volume":"6","author":"T Kawahara","year":"2015","unstructured":"Kawahara T, Kashiwagi E, Ide H et al (2015) Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. Oncotarget 6:1582\u20131593","journal-title":"Oncotarget"},{"key":"2216_CR22","doi-asserted-by":"crossref","unstructured":"Wang Z, Li A, Song Z et al (2025) CypA mediates non-small cell lung cancer chemoresistance by attenuating ferroptosis via stabilizing SLC7A11. Adv Sci (Weinh) e11947","DOI":"10.1002\/advs.202511947"},{"key":"2216_CR23","first-page":"531","volume":"2","author":"AW Tong","year":"1996","unstructured":"Tong AW, Su D, Mues G et al (1996) Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma. Clin Cancer Res 2:531\u2013539","journal-title":"Clin Cancer Res"},{"key":"2216_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2021.06.015","volume":"519","author":"CC Ge","year":"2021","unstructured":"Ge CC, Wang YX, Feng YL et al (2021) Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone. Cancer Lett 519:30\u201345","journal-title":"Cancer Lett"},{"key":"2216_CR25","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1002\/ptr.7933","volume":"37","author":"RH Fan","year":"2023","unstructured":"Fan RH, Wang SZ, Wu YL et al (2023) Activation of endoplasmic reticulum stress by harmine suppresses the growth of esophageal squamous cell carcinoma. Phytother Res 37:4655\u20134673","journal-title":"Phytother Res"},{"key":"2216_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1021\/acs.jmedchem.6b01846","volume":"60","author":"F Dai","year":"2017","unstructured":"Dai F, Li Q, Wang Y et al (2017) Design, synthesis, and biological evaluation of mitochondria-targeted flavone-naphthalimide-polyamine conjugates with antimetastatic activity. J Med Chem 60:2071\u20132083","journal-title":"J Med Chem"},{"key":"2216_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jceh.2022.06.007","volume":"12","author":"C Panackel","year":"2022","unstructured":"Panackel C, Mathew JF, Fawas NM, Jacob M (2022) Immunosuppressive drugs in liver transplant: an insight. J Clin Exp Hepatol 12:1557\u20131571","journal-title":"J Clin Exp Hepatol"},{"key":"2216_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0024-3205(87)90137-8","volume":"40","author":"R Saydjari","year":"1987","unstructured":"Saydjari R, Townsend CM Jr., Barranco SC, Thompson JC (1987) Effects of cyclosporine and alpha-difluoromethylornithine on the growth of mouse colon cancer in vitro. Life Sci 40:359\u2013366","journal-title":"Life Sci"},{"key":"2216_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/CIRCRESAHA.123.322562","volume":"133","author":"JJ Zhou","year":"2023","unstructured":"Zhou JJ, Shao JY, Chen SR, Pan HL (2023) Brain \u03b12\u03b4-1-bound NMDA receptors drive calcineurin inhibitor-induced hypertension. Circ Res 133:611\u2013627","journal-title":"Circ Res"},{"key":"2216_CR30","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3390\/ijms19092697","volume":"19","author":"A Torres","year":"2018","unstructured":"Torres A, Arriagada V, Erices JI et al (2018) FK506 attenuates the MRP1-mediated chemoresistant phenotype in glioblastoma stem-like cells. Int J Mol Sci 19:2697","journal-title":"Int J Mol Sci"},{"key":"2216_CR31","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.21873\/anticanres.16255","volume":"43","author":"JH Park","year":"2023","unstructured":"Park JH, Lee JS, Shin JK et al (2023) Low-dose pimecrolimus, an FDA-approved calcineurin inhibitor, sensitizes drug-resistant cancer cells strong P-gp inhibition. Anticancer Res 43:1103\u20131112","journal-title":"Anticancer Res"},{"key":"2216_CR32","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1007\/s10620-012-2255-8","volume":"57","author":"SH Wang","year":"2012","unstructured":"Wang SH, Kang XM, Cao SQ et al (2012) Calcineurin\/NFATc1 pathway contributes to cell proliferation in hepatocellular carcinoma. Dig Dis Sci 57:3184\u20133188","journal-title":"Dig Dis Sci"},{"key":"2216_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.immuni.2022.03.008","volume":"55","author":"K Peuker","year":"2022","unstructured":"Peuker K, Strigli A, Tauriello DVF et al (2022) Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3-and B7H4-dependent anti-tumor immunity in colorectal cancer. Immunity 55:701-717.e7","journal-title":"Immunity"},{"key":"2216_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ccell.2022.12.009","volume":"41","author":"MA Coelho","year":"2023","unstructured":"Coelho MA, Cooper S, Strauss ME et al (2023) Base editing screens map mutations affecting interferon-gamma signaling in cancer. Cancer Cell 41:288-303.e286","journal-title":"Cancer Cell"},{"key":"2216_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00018-024-05191-6","volume":"81","author":"G Li","year":"2024","unstructured":"Li G, Zhao X, Zheng Z et al (2024) cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors. Cell Mol Life Sci 81:149","journal-title":"Cell Mol Life Sci"},{"key":"2216_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12072-023-10618-6","volume":"18","author":"JX Luo","year":"2024","unstructured":"Luo JX, Zhang Y, Hu XY, Xiang N (2024) Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis. Hepatol Int 18:63\u201372","journal-title":"Hepatol Int"},{"key":"2216_CR37","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1158\/2159-8290.CD-20-1741","volume":"11","author":"XL Zhou","year":"2021","unstructured":"Zhou XL, Singh M, Santos GS et al (2021) Pharmacologic activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting antitumor immunity. Cancer Discov 11:3090\u20133105","journal-title":"Cancer Discov"},{"key":"2216_CR38","doi-asserted-by":"publisher","first-page":"e20202012","DOI":"10.1084\/jem.20202012","volume":"218","author":"DB Stamos","year":"2021","unstructured":"Stamos DB, Clubb LM, Mitra A et al (2021) The histone demethylase Lsd1 regulates multiple repressive gene programs during T cell development. J Exp Med 218:e20202012","journal-title":"J Exp Med"},{"key":"2216_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/0008-5472.CAN-23-1082","volume":"84","author":"HR Tao","year":"2024","unstructured":"Tao HR, Jin C, Zhou LY et al (2024) PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer Res 84:419\u2013433","journal-title":"Cancer Res"},{"key":"2216_CR40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","volume":"18","author":"K Onomoto","year":"2021","unstructured":"Onomoto K, Onoguchi K, Yoneyama M (2021) Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol Immunol 18:539\u2013555","journal-title":"Cell Mol Immunol"},{"key":"2216_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s13238-017-0431-5","volume":"9","author":"XX Xu","year":"2018","unstructured":"Xu XX, Wan H, Nie L et al (2018) RIG-I: a multifunctional protein beyond a pattern recognition receptor. Protein Cell 9:246\u2013253","journal-title":"Protein Cell"},{"key":"2216_CR42","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1038\/s41467-023-41028-9","volume":"14","author":"QQ He","year":"2023","unstructured":"He QQ, Huang Y, Nie LY et al (2023) MAVS integrates glucose metabolism and RIG-I-like receptor signaling. Nat Commun 14:5343","journal-title":"Nat Commun"},{"key":"2216_CR43","doi-asserted-by":"publisher","first-page":"104610","DOI":"10.1016\/j.critrevonc.2024.104610","volume":"207","author":"XC Wang","year":"2025","unstructured":"Wang XC, Wang QW, Zheng CF, Wang LS (2025) MAVS: the next STING in cancers and other diseases. Crit Rev Oncol Hematol 207:104610","journal-title":"Crit Rev Oncol Hematol"},{"key":"2216_CR44","doi-asserted-by":"publisher","first-page":"e108016","DOI":"10.15252\/embj.2021108016","volume":"41","author":"X Zheng","year":"2022","unstructured":"Zheng X, Xiao J, Jiang Q et al (2022) AKT2 reduces IFNbeta1 production to modulate antiviral responses and systemic lupus erythematosus. EMBO J 41:e108016","journal-title":"EMBO J"},{"key":"2216_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.tim.2021.12.011","volume":"30","author":"J Foo","year":"2022","unstructured":"Foo J, Bellot G, Pervaiz S, Alonso S (2022) Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol 30:679\u2013692","journal-title":"Trends Microbiol"},{"key":"2216_CR46","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.2147\/DDDT.S509705","volume":"19","author":"S Do Gan","year":"2025","unstructured":"Do Gan S, Mese A, Baran MF et al (2025) Anticancer, antioxidant and antimicrobial activity of Elaeagnus angustifolia L. Leaf Extract Drug Des Dev Ther 19:7719\u20137734","journal-title":"Leaf Extract Drug Des Dev Ther"},{"key":"2216_CR47","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1080\/15548627.2016.1196318","volume":"12","author":"J Pei","year":"2016","unstructured":"Pei J, Deng J, Ye Z et al (2016) Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells. Autophagy 12:1738\u20131758","journal-title":"Autophagy"},{"key":"2216_CR48","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1073\/pnas.0807694106","volume":"106","author":"MC Tal","year":"2009","unstructured":"Tal MC, Sasai M, Lee HK et al (2009) Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A 106:2770\u20132775","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2216_CR49","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","volume":"28","author":"B Zhou","year":"2018","unstructured":"Zhou B, Zhang JY, Liu XS et al (2018) Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Res 28:1171\u20131185","journal-title":"Cell Res"},{"key":"2216_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jare.2025.01.042","volume":"77","author":"C Liang","year":"2025","unstructured":"Liang C, Liu X, Yu J et al (2025) Hypericin photoactivation induces triple-negative breast cancer cells pyroptosis by targeting the ROS\/CALR\/Caspase-3\/GSDME pathway. J Adv Res 77:669\u2013688","journal-title":"J Adv Res"},{"key":"2216_CR51","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.7150\/ijbs.35094","volume":"15","author":"Y Guo","year":"2019","unstructured":"Guo Y, Li X, Sun X et al (2019) Combined aberrant expression of NDRG2 and LDHA predicts hepatocellular carcinoma prognosis and mediates the anti-tumor effect of gemcitabine. Int J Biol Sci 15:1771\u20131786","journal-title":"Int J Biol Sci"},{"key":"2216_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jcmgh.2022.06.003","volume":"14","author":"M Serra","year":"2022","unstructured":"Serra M, Di Matteo M, Serneels J et al (2022) Deletion of lactate dehydrogenase-A impairs oncogene-induced mouse hepatocellular carcinoma development. Cell Mol Gastroenterol Hepatol 14:609\u2013624","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2216_CR53","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1111\/j.1742-4658.2012.08748.x","volume":"279","author":"SL Sheng","year":"2012","unstructured":"Sheng SL, Liu JJ, Dai YH et al (2012) Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J 279:3898\u20133910","journal-title":"FEBS J"},{"key":"2216_CR54","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1021\/jacs.2c01743","volume":"144","author":"MN Limbach","year":"2022","unstructured":"Limbach MN, Antevska A, Oluwatoba DS et al (2022) Atomic view of aqueous cyclosporine A: unpacking a decades-old mystery. J Am Chem Soc 144:12602\u201312607","journal-title":"J Am Chem Soc"},{"key":"2216_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12645-024-00285-z","volume":"15","author":"S Montazersaheb","year":"2024","unstructured":"Montazersaheb S, Eftekhari A, Shafaroodi A et al (2024) Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC). Cancer Nanotechnol 15:47","journal-title":"Cancer Nanotechnol"},{"key":"2216_CR56","first-page":"262","volume":"10","author":"N Alasgarova","year":"2025","unstructured":"Alasgarova N, Baran A, Y\u0131ld\u0131ztekin M et al (2025) Synthesis of plant-derived selenium nanoparticles from Lankaran-Astara Tea (Camellia sinensis L.) plant and evaluation of their activities on different enzymes. Adv Biol Earth Sci 10:262\u2013269","journal-title":"Adv Biol Earth Sci"},{"key":"2216_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-018-0019-4","volume":"3","author":"W Han","year":"2018","unstructured":"Han W, Shi L, Ren L et al (2018) A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer. Signal Transduct Target Ther 3:16","journal-title":"Signal Transduct Target Ther"},{"key":"2216_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-023-05550-4","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu M, Xie L, Zhang Y et al (2023) Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell Death Dis 14:25","journal-title":"Cell Death Dis"},{"key":"2216_CR59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2022.08.041","volume":"78","author":"N Gillich","year":"2023","unstructured":"Gillich N, Zhang ZF, Binder M, Urban S, Bartenschlager R (2023) Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication. J Hepatol 78:78\u201389","journal-title":"J Hepatol"},{"key":"2216_CR60","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/hep.29105","volume":"65","author":"L Xu","year":"2017","unstructured":"Xu L, Wang WS, Li YL et al (2017) RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology 65:1823\u20131839","journal-title":"Hepatology"},{"key":"2216_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gtc.2020.01.001","volume":"49","author":"H Razavi","year":"2020","unstructured":"Razavi H (2020) Global epidemiology of viral hepatitis. Gastroenterol Clin North Am 49:179\u2013189","journal-title":"Gastroenterol Clin North Am"},{"key":"2216_CR62","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1073\/pnas.1323253111","volume":"111","author":"RC Widau","year":"2014","unstructured":"Widau RC, Parekh AD, Ranck MC et al (2014) RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proc Natl Acad Sci USA 111:E484\u2013E491","journal-title":"Proc Natl Acad Sci USA"},{"key":"2216_CR63","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1158\/0008-5472.CAN-20-2324","volume":"80","author":"WX Zheng","year":"2020","unstructured":"Zheng WX, Ranoa DRE, Huang XN et al (2020) RIG-I-like receptor LGP2 is required for tumor control by radiotherapy. Cancer Res 80:5633\u20135641","journal-title":"Cancer Res"},{"key":"2216_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccr.2013.11.011","volume":"25","author":"J Hou","year":"2014","unstructured":"Hou J, Zhou Y, Zheng YY et al (2014) Hepatic RIG-I predicts survival and interferon-\u03b1 therapeutic response in hepatocellular carcinoma. Cancer Cell 25:49\u201363","journal-title":"Cancer Cell"},{"key":"2216_CR65","doi-asserted-by":"publisher","first-page":"e000111","DOI":"10.1136\/jitc-2019-000111","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Song YQ, Li PD et al (2020) Downregulation of RIG-I mediated by ITGB3\/c-SRC\/STAT3 signaling confers resistance to interferon-\u03b1-induced apoptosis in tumor-repopulating cells of melanoma. J Immunother Cancer 8:e000111","journal-title":"J Immunother Cancer"},{"key":"2216_CR66","doi-asserted-by":"crossref","unstructured":"(2014) RIG-I inhibits SRC-mediated AKT\/mTOR signaling and stemness in AML. Cancer Discov 4:OF19","DOI":"10.1158\/2159-8290.CD-RW2014-015"},{"key":"2216_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13045-022-01381-6","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Zhou Y, Jia K et al (2022) JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis. J Hematol Oncol 15:161","journal-title":"J Hematol Oncol"},{"key":"2216_CR68","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.2147\/OTT.S258450","volume":"13","author":"B Zhou","year":"2020","unstructured":"Zhou B, Li CP, Yang Y, Wang Z (2020) RIG-I promotes cell death in hepatocellular carcinoma by inducing M1 polarization of perineal macrophages through the RIG-I\/MAVS\/NF-\u03baB pathway. Onco Targets Ther 13:8783\u20138794","journal-title":"Onco Targets Ther"},{"key":"2216_CR69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/jir.2018.0125","volume":"39","author":"N Lewczuk","year":"2019","unstructured":"Lewczuk N, Zdebik A, Boguslawska J (2019) Interferon alpha 2a and 2b in ophthalmology: a review. J Interferon Cytokine Res 39:259\u2013272","journal-title":"J Interferon Cytokine Res"},{"key":"2216_CR70","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1158\/1078-0432.CCR-21-4424","volume":"28","author":"MW Loffler","year":"2022","unstructured":"Loffler MW, Gori S, Izzo F et al (2022) Phase I\/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma. Clin Cancer Res 28:2555\u20132566","journal-title":"Clin Cancer Res"},{"key":"2216_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/jir.2024.0195","volume":"45","author":"BS Ulloa","year":"2025","unstructured":"Ulloa BS, Barber-Axthelm I, Berube B et al (2025) Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells. J Interferon Cytokine Res 45:119\u2013132","journal-title":"J Interferon Cytokine Res"},{"key":"2216_CR72","doi-asserted-by":"publisher","first-page":"e73792","DOI":"10.7554\/eLife.73792","volume":"11","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Li Q, Ashraf U et al (2022) Zika virus causes placental pyroptosis and associated adverse fetal outcomes by activating GSDME. Elife 11:e73792","journal-title":"Elife"},{"key":"2216_CR73","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.redox.2017.07.016","volume":"13","author":"Z Agod","year":"2017","unstructured":"Agod Z, Fekete T, Budai MM et al (2017) Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells. Redox Biol 13:633\u2013645","journal-title":"Redox Biol"},{"key":"2216_CR74","doi-asserted-by":"publisher","first-page":"e1000930","DOI":"10.1371\/journal.ppat.1000930","volume":"6","author":"A Soucy-Faulkner","year":"2010","unstructured":"Soucy-Faulkner A, Mukawera E, Fink K et al (2010) Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog 6:e1000930","journal-title":"PLoS Pathog"},{"key":"2216_CR75","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2019.05.003","volume":"178","author":"WN Zhang","year":"2019","unstructured":"Zhang WN, Wang GH, Xu ZG et al (2019) Lactate is a natural suppressor of RLR signaling by targeting MAVS. Cell 178:176-189.e15","journal-title":"Cell"},{"key":"2216_CR76","doi-asserted-by":"publisher","first-page":"217567","DOI":"10.1016\/j.canlet.2025.217567","volume":"616","author":"L Li","year":"2025","unstructured":"Li L, Dong JY, Xu CW, Wang SQ (2025) Lactate drives senescence-resistant lineages in hepatocellular carcinoma via histone H2B lactylation of NDRG1. Cancer Lett 616:217567","journal-title":"Cancer Lett"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02216-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02216-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02216-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:02:44Z","timestamp":1774000964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02216-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02216-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal care and experimentation conformed to the Guide for the Care and Use of Laboratory Animals published by Henan University, and all procedures were approved by the Institutional Animal Care and Use Committee at Henan University (HUSOM2022-091).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"29"}}